<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Johnson & Johnson / Ethicon Inc. on the sale of the wound care business to the Systagenix Wound Management Group | Pestalozzi Attorneys at Law

Pestalozzi advised Johnson & Johnson / Ethicon Inc. on the sale of the wound care business to the Systagenix Wound Management Group

07.2008

Ethicon Inc., a Johnson & Johnson company, received an irrevocable, unconditional offer from One Equity Partners to acquire the Professional Wound Care business. Ethicon conducted a competitive bidding process to prepare for the divestiture of the Professional Wound Care business, and as a result of such process and receipt of the offer decided to grant exclusivity to One Equity Partners. The Professional Wound Care business generated annual net sales of approximately USD 270 million in 2007. The transaction was completed in December 2009. The professional wound care product portfolio is marketed and distributed by Systagenix Wound Management, a new company created by One Equity Partners. Pestalozzi acted as Swiss counsel to Johnson & Johnson / Ethicon.

To the top